Search Contract Opportunities

Carbidopa/Levodopa SA Tablet   3

ID: 36E79725R0008 • Type: Solicitation • Match:  95%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
Does this solicitation list any subcontracting requirements?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

N/A
Background
The Department of Veterans Affairs (VA) is seeking to establish a supply source for pharmaceutical products through its Pharmaceutical Prime Vendor (PPV) Programs. The goal of this contract is to ensure the availability and consistency of Carbidopa/Levodopa SA Tablets for nationwide usage, while obtaining volume-based, committed-use pricing for various government health facilities including the VA, DoD, Indian Health Service, and Bureau of Prisons.

Work Details
The contract involves the supply of two specific pharmaceutical products:

1. Carbidopa 25mg/Levodopa 100mg Tablets, SA - 100 Tablets per Bottle
- Base Year Quantity: 60,932 Bottles
- Option Year One Quantity: 60,932 Bottles
- Option Year Two Quantity: 60,932 Bottles
- Option Year Three Quantity: 60,932 Bottles
- Option Year Four Quantity: 60,932 Bottles

2. Carbidopa 50mg/Levodopa 200mg Tablets, SA - 100 Tablets per Bottle
- Base Year Quantity: 58,943 Bottles
- Option Year One Quantity: 58,943 Bottles
- Option Year Two Quantity: 58,943 Bottles
- Option Year Three Quantity: 58,943 Bottles
- Option Year Four Quantity: 58,943 Bottles.

All offered prices must include a Cost Recovery Fee of 0.5% and shall not exceed two decimal places.

Period of Performance
The contract will be effective upon the signing of the SF-1449 by the VA and will include a maximum implementation period of up to 60 days following the award date.

Place of Performance
Products will be delivered to various locations as specified by the VA and DoD Pharmaceutical Prime Vendor Programs.

Overview

Response Deadline
Jan. 30, 2025, 3:30 p.m. EST Past Due
Posted
Jan. 16, 2025, 4:41 p.m. EST
Set Aside
None
Place of Performance
Not Provided
Source

Current SBA Size Standard
1300 Employees
Pricing
Likely Fixed Price
Est. Level of Competition
Average
Est. Value Range
Experimental
$1,000,000 - $5,000,000 (AI estimate)
On 1/16/25 National Acquisition Center issued Solicitation 36E79725R0008 for Carbidopa/Levodopa SA Tablet due 1/30/25. The opportunity was issued full & open with NAICS 325412 and PSC 6505.
Primary Contact
Title
Contract Specialist
Name
Christopher Carthron   Profile
Phone
None

Documents

Posted documents for Solicitation 36E79725R0008

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Opportunity Lifecycle

Procurement notices related to Solicitation 36E79725R0008

Award Notifications

Agency published notification of awards for Solicitation 36E79725R0008

IDV Awards

Indefinite delivery vehicles awarded through Solicitation 36E79725R0008

Incumbent or Similar Awards

Contracts Similar to Solicitation 36E79725R0008

Potential Bidders and Partners

Awardees that have won contracts similar to Solicitation 36E79725R0008

Similar Active Opportunities

Open contract opportunities similar to Solicitation 36E79725R0008

Additional Details

Source Agency Hierarchy
VETERANS AFFAIRS, DEPARTMENT OF > VETERANS AFFAIRS, DEPARTMENT OF > NAC PHARMACEUTICALS (36E797)
FPDS Organization Code
3600-36E797
Source Organization Code
500000036
Last Updated
May 9, 2025
Last Updated By
Christopher.Carthron@va.gov
Archive Date
May 9, 2025